Skip to main content
. 2017 Apr 18;12(4):e0175990. doi: 10.1371/journal.pone.0175990

Table 3. Effect of LEV administration on sperm morphology.

Experimental Groups Abnormal Sperm (%) Head Abnormality (%) Tail Abnormality (%) Multiple Abnormality (%)
C 24.85 ± 4.88 8.75 ± 3.22 12.4 ± 3.74 3.7 ± 1.58
LEV-50 38.7 ± 2.98 13.55 ± 3.24 18.3 ± 2.09 6.5 ± 2.04
LEV-150 46.3 ± 7.02 (a) 13.3 ± 3.14 25.85 ± 3.34 (a) 7.15 ± 2.75 (a)
LEV-300 59.25 ± 7.21 (aaa,b) 15.05 ± 3.59 (a) 35.5 ± 4.47 (aaa,b) 8.7 ± 3.72 (a)

C: Control group; LEV-50: 50 mg/kg levetiracetam administered group; LEV-150: 150 mg/kg levetiracetam administered group; LEV-300: 300 mg/kg levetiracetam administered group; Results are Mean ± SD, n = 10.

(a) Different from control group (P < 0.05),

(aaa) Different from control group (P < 0.001),

(b) Different from LEV-50 (P < 0.05).